TKI Targeted Therapy in Advanced Hepatocellular Cancer
Sort by:
Moffitt Cancer Center
Moffitt Cancer Center Update on Advanced HCC: Is 1L Sorafenib Beneficial vs. Atezo + Bev? Can TKIs Be Used as 2L/3L Therapy?
FEATURING
Richard Kim
- 180 views
- December 28, 2020
- 1
Northwestern Medicine Oncology and Hematology
Down-staging of Hepatocellular Carcinoma and Current Therapeutic Landscape in HCC
FEATURING
Laura M Kulik
- 296 views
- January 10, 2019
- 1
Symposium on Clinical Interventional Oncology (CIO 2018)
What IO Missed in Colorectal and Liver Cancer: A Medical Oncologist’s View
FEATURING
Santiago Aparo
- 462 views
- March 28, 2018
- 1
SYNERGY
Multidisciplinary Strategies to Improve Treatment Outcomes in Hepatocellular Carcinoma
FEATURING
Riccardo Lencioni
- 440 views
- March 25, 2015